Relevance of Antibody Validation for Flow Cytometry

Antibody reagents are the key components of multiparametric flow cytometry analysis. Their quality performance is an absolute requirement for reproducible flow cytometry experiments. While there is an enormous body of antibody reagents available, there is still a lack of consensus about which criteria should be evaluated to select antibody reagents with the proper performance, how to validate antibody reagents for flow cytometry, and how to interpret the validation results. The achievements of cytometry moved the field to a higher number of measured parameters, large data sets, and computational data analysis approaches. These advancements pose an increased demand for antibody reagent performance quality. This review summarizes the codevelopment of cytometry, antibody development, and validation strategies. It discusses the diverse issues of the specificity, cross‐reactivity, epitope, titration, and reproducibility features of antibody reagents, and this review discusses the validation principles and methods that are currently available and those that are emerging. We argue that significant efforts should be invested by antibody users, developers, manufacturers, and publishers to increase the quality and reproducibility of published studies. More validation data should be presented by all stakeholders; however, the data should be presented in sufficient experimental detail to foster reproducibility, and community effort shall lead to the public availability of large data sets that can serve as a benchmark for antibody performance. © 2019 International Society for Advancement of Cytometry

[1]  Demin Li,et al.  The European antibody network's practical guide to finding and validating suitable antibodies for research , 2015, mAbs.

[2]  Tomas Kalina,et al.  Multiplexed immuno‐precipitation with 1725 commercially available antibodies to cellular proteins , 2011, Proteomics.

[3]  R. Brant,et al.  A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies. , 2018, JCI insight.

[4]  D. Hedley,et al.  Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[5]  C. E. Pedreira,et al.  Quality assessment program for EuroFlow protocols: Summary results of four‐year (2010–2013) quality assurance rounds , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[6]  Emma Lundberg,et al.  A proposal for validation of antibodies , 2016, Nature Methods.

[7]  A Orfao,et al.  Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma , 2017, Leukemia.

[8]  Fridtjof Lund-Johansen,et al.  Antibody Array Analysis with Label-based Detection and Resolution of Protein Size *S , 2009, Molecular & Cellular Proteomics.

[9]  T. Springer César Milstein, the father of modern immunology , 2002, Nature Immunology.

[10]  M. Roederer,et al.  OMIP‐051 – 28‐color flow cytometry panel to characterize B cells and myeloid cells , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  Bartek Rajwa,et al.  Hyperspectral cytometry. , 2014, Current topics in microbiology and immunology.

[12]  V. Nesterenko,et al.  [Multispecific monoclonal antibodies]. , 1991, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[13]  Lars R Olsen,et al.  The anatomy of single cell mass cytometry data. , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[14]  Shannon McWeeney,et al.  MIFlowCyt: The minimum information about a flow cytometry experiment , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  T. Wieland,et al.  How reliable are G-protein-coupled receptor antibodies? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  G. Casari,et al.  A reversible gene trap collection empowers haploid genetics in human cells , 2013, Nature Methods.

[17]  Mario Roederer,et al.  A chromatic explosion: the development and future of multiparameter flow cytometry , 2008, Immunology.

[18]  Sean C. Bendall,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[19]  D. Sutherland,et al.  High‐sensitivity 5‐, 6‐, and 7‐color PNH WBC assays for both Canto II and Navios platforms , 2018, Cytometry. Part B, Clinical cytometry.

[20]  Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins. , 2002, Blood.

[21]  M. Uhlén,et al.  Antibodypedia, a Portal for Sharing Antibody and Antigen Validation Data*S , 2008, Molecular & Cellular Proteomics.

[22]  T. Kalina,et al.  Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation , 2018, Journal of Clinical Immunology.

[23]  F. Lund-Johansen,et al.  Should we ignore western blots when selecting antibodies for other applications? , 2017, Nature Methods.

[24]  A Orfao,et al.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes , 2012, Leukemia.

[25]  Carl-Magnus Clausson,et al.  Insufficient antibody validation challenges oestrogen receptor beta research , 2017, Nature Communications.

[26]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies. , 2017, European journal of immunology.

[27]  OMIP‐045: Characterizing human head and neck tumors and cancer cell lines with mass cytometry , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[28]  M. O'gorman Flow Cytometry Assays in Primary Immunodeficiency Diseases. , 2018, Methods in molecular biology.

[29]  Andrew D Chalmers,et al.  Reporting research antibody use: how to increase experimental reproducibility , 2013, F1000Research.

[30]  Hannes Stockinger,et al.  CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology , 2015, The Journal of Immunology.

[31]  M. Uhlén Response to: Should we ignore western blots when selecting antibodies for other applications? , 2017, Nature Methods.

[32]  Rachel E. Owen,et al.  The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[33]  Mariana Valente,et al.  Spectral Cytometry Has Unique Properties Allowing Multicolor Analysis of Cell Suspensions Isolated from Solid Tissues , 2016, PloS one.

[34]  I. Cockburn,et al.  The Economics of Reproducibility in Preclinical Research , 2015, PLoS biology.

[35]  Greg Finak The Computational article format: Software as a research output , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  P. Wallace,et al.  ICCS/ESCCA Consensus Guidelines to detect GPI‐deficient cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders Part 2 – Reagent Selection and Assay Optimization for High‐Sensitivity Testing , 2018, Cytometry. Part B, Clinical cytometry.

[37]  M. van der Burg,et al.  Age‐associated distribution of normal B‐cell and plasma cell subsets in peripheral blood , 2018, The Journal of allergy and clinical immunology.

[38]  Josef Spidlen,et al.  Preparing a Minimum Information about a Flow Cytometry Experiment (MIFlowCyt) Compliant Manuscript Using the International Society for Advancement of Cytometry (ISAC) FCS File Repository (FlowRepository.org) , 2012, Current protocols in cytometry.

[39]  Isao Ishida,et al.  Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen , 2004, International journal of cancer.

[40]  J. Paul Robinson,et al.  Hyperspectral cytometry at the single‐cell level using a 32‐channel photodetector , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[41]  Holden T Maecker,et al.  Algorithmic Tools for Mining High-Dimensional Cytometry Data , 2015, The Journal of Immunology.

[42]  Ryan R Brinkman,et al.  Implementation and Validation of an Automated Flow Cytometry Analysis Pipeline for Human Immune Profiling , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[43]  Fridtjof Lund-Johansen,et al.  Antibody array analysis of labelled proteomes: how should we control specificity? , 2012, New biotechnology.

[44]  D. Sutherland,et al.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. , 1996, Journal of hematotherapy.

[45]  B. Autran,et al.  Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity. , 2007, Journal of immunological methods.

[46]  L. Pilarski,et al.  Selective expression of CD45 isoforms and of maturation antigens during human thymocyte differentiation: observations and hypothesis. , 1989, Immunology letters.

[47]  M. Baker Reproducibility crisis: Blame it on the antibodies , 2015, Nature.

[48]  T. Kalina,et al.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.

[49]  A. Bernard,et al.  The clusters of differentiation (CD) defined by the First International Workshop on Human Leucocyte Differentiation Antigens. , 1984, Human immunology.

[50]  N. Aghaeepour,et al.  Thinking outside the gate: single-cell assessments in multiple dimensions. , 2015, Immunity.

[51]  F. Craig,et al.  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry , 2010, Cytometry. Part B, Clinical cytometry.

[52]  O. Ornatsky,et al.  Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. , 2009, Analytical chemistry.

[53]  R. de Waal Malefyt,et al.  Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions. , 2000, Cytometry.

[54]  Tuula A Nyman,et al.  A high-throughput pipeline for validation of antibodies , 2018, Nature Methods.

[55]  Jeffrey A. Wiser,et al.  ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.

[56]  Josef Spidlen,et al.  FlowRepository: A resource of annotated flow cytometry datasets associated with peer‐reviewed publications , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[57]  H. Maecker,et al.  A Model for Harmonizing Flow Cytometry in Clinical Trials , 2022 .

[58]  P. Whitley,et al.  CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited , 2014, BMC Cell Biology.

[59]  B. Becher,et al.  The end of gating? An introduction to automated analysis of high dimensional cytometry data , 2016, European journal of immunology.

[60]  P. Chattopadhyay,et al.  Publication of optimized multicolor immunofluorescence panels , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[61]  R. Hulspas,et al.  Titration of Fluorochrome‐Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells , 2010, Current protocols in cytometry.

[62]  Mario Roederer,et al.  OMIP‐001: Quality and phenotype of Ag‐responsive human T‐cells , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[63]  Valsamo Anagnostou,et al.  Antibody validation. , 2010, BioTechniques.

[64]  Monya Baker,et al.  Antibody anarchy: A call to order , 2015, Nature.

[65]  M. V. van Zelm,et al.  Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop , 2016, Clinical & translational immunology.

[66]  P. Chattopadhyay,et al.  OMIP‐050: A 28‐color/30‐parameter Fluorescence Flow Cytometry Panel to Enumerate and Characterize Cells Expressing a Wide Array of Immune Checkpoint Molecules , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[67]  Tomáš Kalina,et al.  An automated analysis of highly complex flow cytometry‐based proteomic data , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.